Targeted probiotics with high efficacy.

About us

We are a biotechnology company developing probiotic strains with proven mechanisms of action

SURI BioTech is a pioneering biotechnology company specializing in microbiome solutions for health and well-being. With a focus on innovation and efficacy, we develop bacterial strains with proven mechanisms of action.

We are dedicated to improve people’s health by targeting the microbiome.

We are led by knowledge.

Dr. sc. Vanesa Rocha Martin, our CEO, has committed her professional career to study microbes. She has dedicated over 13 years of her life to study gut microbes, focusing on their impact on health.

Throughout her veterinarian and food science studies, Vanesa developed a particular interest for the gut microbiota and its metabolic potential. It was after her PhD research at ETH Zürich when she decided to translate her findings into solutions with real benefits for the consumers.

SURI BioTech GmbH was established in Switzerland in March 2023. We are a recognized ETH Zürich spin-off.

Awards and recognitions